Value in Health, the official journal of ISPOR—the professional society for health economics and outcomes research, announced today the publication of new research showing that insurer approval rates for PCSK9i prescriptions remain low.

news, journals and articles from all over the world.
Value in Health, the official journal of ISPOR—the professional society for health economics and outcomes research, announced today the publication of new research showing that insurer approval rates for PCSK9i prescriptions remain low.
Starting in 2016, a two-year partnership between the North Carolina Chapter of the American College of Cardiology (NCACC) and the North Carolina Association of Free and Charitable Clinics (NCAFCC) provided free lipid lowering therapy and clopidogrel to patients at seven free clinics in North Carolina. The results of this pilot study were recently published in the Journal of the American College of Cardiology.